Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE54.1400
- TODAY'S CHANGE (%)0.4700 (0.8757%)
- Bid / Lots52.0000/ 1
- Ask / Lots54.3000/ 13
- Open / Previous Close53.3900 / 53.6700
- Day Range
- 52 Week Range
- Volume905,121
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 9678 | 53.4 |
| 09:34 ET | 1333 | 53.1725 |
| 09:36 ET | 200 | 53.35 |
| 09:38 ET | 900 | 53.2801 |
| 09:39 ET | 900 | 53.88 |
| 09:41 ET | 100 | 53.72 |
| 09:43 ET | 935 | 53.47 |
| 09:45 ET | 900 | 53.805 |
| 09:48 ET | 9012 | 53.9 |
| 09:50 ET | 600 | 53.96 |
| 09:52 ET | 100 | 53.78 |
| 09:54 ET | 200 | 53.83 |
| 09:56 ET | 2100 | 54.255 |
| 09:57 ET | 640 | 54.43 |
| 09:59 ET | 3100 | 54.715 |
| 10:01 ET | 1200 | 54.69 |
| 10:03 ET | 200 | 54.675 |
| 10:06 ET | 1080 | 54.5 |
| 10:08 ET | 4406 | 54.61 |
| 10:10 ET | 1140 | 54.56 |
| 10:12 ET | 808 | 54.56 |
| 10:14 ET | 500 | 54.5 |
| 10:15 ET | 5754 | 54.705 |
| 10:17 ET | 5822 | 54.52 |
| 10:19 ET | 2227 | 54.5682 |
| 10:21 ET | 1300 | 54.61 |
| 10:24 ET | 700 | 54.5 |
| 10:26 ET | 500 | 54.685 |
| 10:28 ET | 200 | 54.59 |
| 10:30 ET | 1844 | 54.71 |
| 10:32 ET | 938 | 54.63 |
| 10:33 ET | 2000 | 54.89 |
| 10:35 ET | 400 | 54.87 |
| 10:37 ET | 836 | 54.76 |
| 10:39 ET | 1398 | 54.585 |
| 10:42 ET | 1000 | 54.5 |
| 10:44 ET | 1419 | 54.56 |
| 10:46 ET | 4634 | 54.41 |
| 10:48 ET | 300 | 54.36 |
| 10:50 ET | 615 | 54.34 |
| 10:51 ET | 6700 | 54.52 |
| 10:53 ET | 9395 | 54.48 |
| 10:55 ET | 9995 | 54.54 |
| 10:57 ET | 12000 | 54.57 |
| 11:00 ET | 1000 | 54.54 |
| 11:02 ET | 900 | 54.68 |
| 11:04 ET | 400 | 54.705 |
| 11:06 ET | 1000 | 54.72 |
| 11:08 ET | 2239 | 54.55 |
| 11:09 ET | 900 | 54.57 |
| 11:11 ET | 1900 | 54.61 |
| 11:13 ET | 4095 | 54.69 |
| 11:15 ET | 9242 | 54.82 |
| 11:18 ET | 956 | 54.72 |
| 11:20 ET | 1000 | 54.84 |
| 11:22 ET | 2242 | 54.97 |
| 11:24 ET | 936 | 54.885 |
| 11:26 ET | 29675 | 54.82 |
| 11:27 ET | 562 | 54.845 |
| 11:29 ET | 1043 | 54.665 |
| 11:31 ET | 400 | 54.68 |
| 11:33 ET | 3401 | 54.685 |
| 11:36 ET | 400 | 54.685 |
| 11:38 ET | 1808 | 54.75 |
| 11:40 ET | 2396 | 54.875 |
| 11:42 ET | 3500 | 54.89 |
| 11:44 ET | 2957 | 54.86 |
| 11:45 ET | 500 | 54.92 |
| 11:47 ET | 200 | 54.87 |
| 11:49 ET | 200 | 54.84 |
| 11:51 ET | 700 | 54.84 |
| 11:54 ET | 2701 | 54.84 |
| 11:56 ET | 502 | 54.9 |
| 11:58 ET | 644 | 54.875 |
| 12:00 ET | 128549 | 55.17 |
| 12:02 ET | 3955 | 54.935 |
| 12:03 ET | 1000 | 54.935 |
| 12:05 ET | 1526 | 54.75 |
| 12:07 ET | 2337 | 54.68 |
| 12:09 ET | 300 | 54.59 |
| 12:12 ET | 1500 | 54.495 |
| 12:14 ET | 200 | 54.24 |
| 12:16 ET | 1458 | 54.1 |
| 12:18 ET | 3526 | 54.14 |
| 12:20 ET | 7232 | 54.26 |
| 12:21 ET | 600 | 54.26 |
| 12:23 ET | 881 | 54.31 |
| 12:25 ET | 6259 | 54.245 |
| 12:27 ET | 200 | 54.08 |
| 12:30 ET | 700 | 53.94 |
| 12:32 ET | 1600 | 53.92 |
| 12:34 ET | 200 | 53.94 |
| 12:36 ET | 2155 | 53.92 |
| 12:38 ET | 200 | 53.9 |
| 12:39 ET | 1176 | 53.76 |
| 12:41 ET | 4761 | 53.87 |
| 12:43 ET | 2110 | 53.94 |
| 12:45 ET | 1000 | 53.88 |
| 12:48 ET | 2455 | 53.87 |
| 12:52 ET | 100 | 53.84 |
| 12:54 ET | 2185 | 53.87 |
| 12:56 ET | 2029 | 53.905 |
| 12:57 ET | 1130 | 53.76 |
| 12:59 ET | 100 | 53.76 |
| 01:01 ET | 817 | 53.595 |
| 01:03 ET | 1886 | 53.63 |
| 01:06 ET | 900 | 53.65 |
| 01:08 ET | 900 | 53.62 |
| 01:10 ET | 1294 | 53.74 |
| 01:12 ET | 600 | 53.825 |
| 01:14 ET | 225 | 53.815 |
| 01:15 ET | 300 | 53.91 |
| 01:17 ET | 1742 | 53.89 |
| 01:19 ET | 100 | 53.93 |
| 01:21 ET | 772 | 53.9322 |
| 01:24 ET | 2611 | 54.05 |
| 01:26 ET | 600 | 54.03 |
| 01:28 ET | 1315 | 54.06 |
| 01:30 ET | 414 | 54 |
| 01:32 ET | 527 | 54 |
| 01:33 ET | 600 | 53.835 |
| 01:35 ET | 10400 | 53.76 |
| 01:37 ET | 2512 | 53.91 |
| 01:39 ET | 200 | 53.84 |
| 01:42 ET | 200 | 53.84 |
| 01:44 ET | 200 | 53.835 |
| 01:46 ET | 600 | 53.91 |
| 01:48 ET | 1307 | 53.9407 |
| 01:50 ET | 339 | 53.905 |
| 01:51 ET | 100 | 53.86 |
| 01:53 ET | 1100 | 53.98 |
| 01:55 ET | 424 | 53.88 |
| 01:57 ET | 100 | 53.93 |
| 02:00 ET | 501 | 53.98 |
| 02:02 ET | 1920 | 54.035 |
| 02:04 ET | 1297 | 54.03 |
| 02:06 ET | 125 | 54.0906 |
| 02:08 ET | 900 | 53.95 |
| 02:09 ET | 600 | 54 |
| 02:11 ET | 2211 | 53.89 |
| 02:13 ET | 100 | 53.86 |
| 02:15 ET | 800 | 53.9 |
| 02:18 ET | 4424 | 54 |
| 02:20 ET | 1105 | 53.95 |
| 02:22 ET | 1021 | 54.015 |
| 02:24 ET | 2129 | 54.1 |
| 02:26 ET | 500 | 54.05 |
| 02:27 ET | 200 | 54.01 |
| 02:29 ET | 1100 | 53.94 |
| 02:31 ET | 700 | 53.915 |
| 02:33 ET | 1000 | 53.91 |
| 02:36 ET | 1300 | 53.955 |
| 02:38 ET | 1200 | 53.96 |
| 02:40 ET | 2285 | 54.005 |
| 02:42 ET | 3500 | 54.06 |
| 02:44 ET | 300 | 54 |
| 02:45 ET | 300 | 54.055 |
| 02:47 ET | 1200 | 54.045 |
| 02:49 ET | 695 | 54.1 |
| 02:51 ET | 1100 | 54.1 |
| 02:54 ET | 1522 | 54.14 |
| 02:56 ET | 800 | 54.2 |
| 02:58 ET | 1100 | 54.15 |
| 03:00 ET | 700 | 54.18 |
| 03:02 ET | 696 | 54.06 |
| 03:03 ET | 2634 | 54.165 |
| 03:05 ET | 13551 | 54.135 |
| 03:07 ET | 7900 | 54.13 |
| 03:09 ET | 600 | 54.105 |
| 03:12 ET | 400 | 54.04 |
| 03:14 ET | 800 | 54.0975 |
| 03:16 ET | 1679 | 54.13 |
| 03:18 ET | 300 | 54.14 |
| 03:20 ET | 1400 | 54.165 |
| 03:21 ET | 2000 | 54.3 |
| 03:23 ET | 6378 | 54.42 |
| 03:25 ET | 700 | 54.475 |
| 03:27 ET | 13343 | 54.31 |
| 03:30 ET | 828 | 54.245 |
| 03:32 ET | 2823 | 54.374 |
| 03:34 ET | 4099 | 54.38 |
| 03:36 ET | 3700 | 54.375 |
| 03:38 ET | 4245 | 54.455 |
| 03:39 ET | 1202 | 54.44 |
| 03:41 ET | 500 | 54.425 |
| 03:43 ET | 3521 | 54.455 |
| 03:45 ET | 3719 | 54.4 |
| 03:48 ET | 4700 | 54.22 |
| 03:50 ET | 4108 | 54.335 |
| 03:52 ET | 8108 | 54.38 |
| 03:54 ET | 20367 | 54.11 |
| 03:56 ET | 9731 | 54.08 |
| 03:57 ET | 8542 | 54.2 |
| 03:59 ET | 122282 | 54.14 |
Jul 10, 2024
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:29PM ET on Wednesday Jul 10, 2024 by Dow Jones
7:29PM ET on Wednesday Jul 10, 2024 by Dow Jones
Jul 9, 2024
DJ Crinetics Pharmaceuticals Is Maintained at Overweight by JP Morgan, from 11:09AM ET on Tuesday Jul 09, 2024 by Dow Jones
11:09AM ET on Tuesday Jul 09, 2024 by Dow Jones
Jul 2, 2024
DJ Crinetics Pharmaceuticals Is Maintained at Overweight by Piper Sandler, from 1:39PM ET on Tuesday Jul 02, 2024 by Dow Jones
1:39PM ET on Tuesday Jul 02, 2024 by Dow Jones
Jun 28, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 6:57AM ET on Friday Jun 28, 2024 by Dow Jones
6:57AM ET on Friday Jun 28, 2024 by Dow Jones
Jun 18, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.2B | -14.4x | --- |
Dyne Therapeutics Inc | 4.1B | -10.9x | --- |
Immunovant Inc | 4.5B | -16.2x | --- |
Immunitybio Inc | 4.6B | -6.0x | --- |
Avidity Biosciences Inc | 4.8B | -15.5x | --- |
Merus NV | 3.9B | -21.3x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.2B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.70 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -14.4x |
Price/Sales (TTM) | 2,144.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
